Results 261 to 270 of about 639,100 (318)
Natural killer cells in the lung: novel insight and future challenge in the airway diseases. [PDF]
Pianigiani T+5 more
europepmc +1 more source
This study introduces KK2DP7, a dendrimer‐structured peptide adjuvant, as a tool to decode trained immunity's role in antitumor therapy. Splenic CD11b+ cells mediate tumor suppression via TLR2‐IRF7 activation and epigenetic reprogramming, validated by adoptive transfer experiments.
Rui Zhang+5 more
wiley +1 more source
A theranostic nanoplatform is formulated with NIR‐II emissive lipophilic cyanine dye IRC18 to intercalate into genetically engineered IL12/CSF1R‐macrophage membrane‐liposome hybrid nanovesicles, which assists to achieve blood–brain barrier crossing, glioblastoma targeting, NIR‐II fluorescence imaging, image‐guided membrane‐targeted mild photothermal ...
Pengfei Chen+10 more
wiley +1 more source
Research Advances in the Immunomodulatory Functions of CD100/SEMA4D and Their Roles in Viral Infectious Diseases. [PDF]
Zhao M+7 more
europepmc +1 more source
The study develops engineered exosomes (EmDEX@GA) for locoregional immunomodulation of tumor‐draining lymph node (TDLN). EmDEX@GA can actively target to TDLN and remodel its immunosuppressive microenvironment through the synergistic effects of PD‐1/PD‐L1 blockade and STING pathway activation, subsequently enhance anti‐tumor immunity and suppress tumor ...
Yizhen Wang+12 more
wiley +1 more source
<i>Metschnikowia pulcherrima</i> and <i>Lachancea thermotolerans</i> Killer Toxins: Contribution to Must Bioprotection. [PDF]
El Dana F+6 more
europepmc +1 more source
Synthetic gene circuits regulated by bezafibrate are developed to express tumor antigens and PD‐L1 nanobody (PD‐L1nb), enhancing cancer immunotherapy. Delivered via HEK293T cells, ESCs, or directly injected the plasmids containing the circuit into the tumor, the circuits reduce tumor growth, boost CD8+ T cells, and minimize T cell exhaustion.
Meiling Jin+3 more
wiley +1 more source
Adoptively transferred macrophages for cancer immunotherapy. [PDF]
Park KS+8 more
europepmc +1 more source
Elephant in the room: natural killer cells don't forget HIV either. [PDF]
Jost S, Reeves RK.
europepmc +1 more source
The first reported death of iNKLPD-GI: rethinking "watch and wait" strategy. [PDF]
He K, Zhou Q, Wang Y, Jia C, Wu D.
europepmc +1 more source